BONNIE V SEECHARRAN M.D NPI 1891796645

NPI Details

Bonnie V Seecharran, M.D is a cardiovascular disease internal medicine in Middletown, NY with 36 years of experience. The provider is an internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms. Bonnie V Seecharran, M.D NPI is 1891796645. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

111 MALTESE DR
MIDDLETOWN, NY
ZIP 10940-115
Phone: (845) 342-4774
Fax: (845) 818-7555

The NPI 1891796645 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Injection, regadenoson, 0.1 mg (HCPCS:J2785)
• Technetium tc-99m tetrofosmin, diagnostic, per study dose (HCPCS:A9502)
• Hemoglobin a1c level (HCPCS:83036)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
• Nuclear medicine studies of heart muscle at rest and with stress and spect (HCPCS:78452)
• Uric acid level, blood (HCPCS:84550)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Vitamin d-3 level (HCPCS:82306)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Electrocardiogram (ecg) 2-day continuous with review and report by health care professional (HCPCS:93224)
• Blood test, clotting time (HCPCS:85610)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Ct scan of chest without contrast (HCPCS:71250)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• Myoglobin (muscle protein) level (HCPCS:83874)
• Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report (HCPCS:93784)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional (HCPCS:93228)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Urinalysis, manual test (HCPCS:81002)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Follow-up observation care per day, typically 25 minutes (HCPCS:99225)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional (HCPCS:93229)
• Magnesium level (HCPCS:83735)
• Initial hospital observation care per day, typically 70 minutes (HCPCS:99220)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Ct scan head or brain without contrast (HCPCS:70450)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)

The enumeration date for this NPI number is 8/2/2005 and was last updated on 4/16/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.